Literature DB >> 23079585

The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.

Alina Filatova1, Till Acker, Boyan K Garvalov.   

Abstract

BACKGROUND: The initiation and progression of various types of tumors, including glioma, are driven by a population of cells with stem cell properties. Glioma stem cells (GSCs) are located in specialized microenvironments (niches) within tumors. These niches represent the hallmarks of malignant gliomas (vascular proliferations, hypoxia/necrosis) and bear analogy to the microenvironments in which physiological stem cells in the brain are found. SCOPE OF THE REVIEW: Here we review the progress that has been made towards uncovering the function of the perivascular and the hypoxic niche and the molecular pathways that control the properties of GSCs within them. We propose models of how the different niches and GSC pools in them interact with each other. MAJOR
CONCLUSIONS: GSCs are not merely passive residents of their niches, but actively contribute to the shaping of the niches through a complex crosstalk with different components of the microenvironment. For example, GSCs play a dominant role in promoting new blood vessel formation through a variety of mechanisms, including the hypoxia dependent stimulation of angiogenesis, recruitment of endothelial progenitor cells and direct transdifferentiation into endothelial cells. Recent work has also revealed that GSCs can recruit and modulate the function of various immune cells to suppress anti-tumor immune responses and to foster tumor-promoting inflammation, which in turn could support the maintenance of GSCs. GENERAL SIGNIFICANCE: These findings underscore the central role of the GSC microenvironment in driving glioma progression making the GSC niche a prime therapeutic target for the design of therapies aimed at eradicating GSCs. This article is part of a Special Issue entitled Biochemistry of Stem Cells.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23079585     DOI: 10.1016/j.bbagen.2012.10.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

Review 1.  Cervical cancer stem cells.

Authors:  Tingting Yao; Rongbiao Lu; Yizhen Zhang; Ya Zhang; Chenyang Zhao; Rongchun Lin; Zhongqiu Lin
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

Review 2.  Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.

Authors:  Francesca Pistollato; Susanne Bremer-Hoffmann; Giuseppe Basso; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

Review 3.  Glioblastoma niches: from the concept to the phenotypical reality.

Authors:  Davide Schiffer; Marta Mellai; Enrica Bovio; Ilaria Bisogno; Cristina Casalone; Laura Annovazzi
Journal:  Neurol Sci       Date:  2018-05-08       Impact factor: 3.307

4.  Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis.

Authors:  Nathaniel H Boyd; Kiera Walker; Adetokunbo Ayokanmbi; Emily R Gordon; Julia Whetsel; Cynthia M Smith; Richard G Sanchez; Farah D Lubin; Asmi Chakraborty; Anh Nhat Tran; Cameron Herting; Dolores Hambardzumyan; G Yancey Gillespie; James R Hackney; Sara J Cooper; Kai Jiao; Anita B Hjelmeland
Journal:  Stem Cells       Date:  2019-01-24       Impact factor: 6.277

Review 5.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

6.  A comprehensive view of tumor stem cells and their regulation by the microenvironment in glioblastoma.

Authors:  Davide Schiffer; Laura Annovazzi; Marta Mellai
Journal:  Neurol Sci       Date:  2016-11-16       Impact factor: 3.307

7.  Constitutive activation of myosin-dependent contractility sensitizes glioma tumor-initiating cells to mechanical inputs and reduces tissue invasion.

Authors:  Sophie Y Wong; Theresa A Ulrich; Loic P Deleyrolle; Joanna L MacKay; Jung-Ming G Lin; Regina T Martuscello; Musa A Jundi; Brent A Reynolds; Sanjay Kumar
Journal:  Cancer Res       Date:  2015-01-29       Impact factor: 12.701

8.  A niche role for periostin and macrophages in glioblastoma.

Authors:  Mario Leonardo Squadrito; Michele De Palma
Journal:  Nat Cell Biol       Date:  2015-02       Impact factor: 28.824

9.  Cancer stem cells in glioma: challenges and opportunities.

Authors:  Jialiang Wang; Yufang Ma; Michael K Cooper
Journal:  Transl Cancer Res       Date:  2013-10-01       Impact factor: 1.241

10.  EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.

Authors:  Qi Yu; Libo Liu; Ping Wang; Yilong Yao; Yixue Xue; Yunhui Liu
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.